Learning Personal Representations from fMRIby Predicting Neurofeedback Performance
Authors:
Jhonathan Osin,
Lior Wolf,
Guy Gurevitch,
Jackob Nimrod Keynan,
Tom Fruchtman-Steinbok,
Ayelet Or-Borichev,
Shira Reznik Balter,
Talma Hendler
Abstract:
We present a deep neural network method for learning a personal representation for individuals that are performing a self neuromodulation task, guided by functional MRI (fMRI). This neurofeedback task (watch vs. regulate) provides the subjects with a continuous feedback contingent on down regulation of their Amygdala signal and the learning algorithm focuses on this region's time-course of activit…
▽ More
We present a deep neural network method for learning a personal representation for individuals that are performing a self neuromodulation task, guided by functional MRI (fMRI). This neurofeedback task (watch vs. regulate) provides the subjects with a continuous feedback contingent on down regulation of their Amygdala signal and the learning algorithm focuses on this region's time-course of activity. The representation is learned by a self-supervised recurrent neural network, that predicts the Amygdala activity in the next fMRI frame given recent fMRI frames and is conditioned on the learned individual representation. It is shown that the individuals' representation improves the next-frame prediction considerably. Moreover, this personal representation, learned solely from fMRI images, yields good performance in linear prediction of psychiatric traits, which is better than performing such a prediction based on clinical data and personality tests. Our code is attached as supplementary and the data would be shared subject to ethical approvals.
△ Less
Submitted 6 December, 2021;
originally announced December 2021.
A Bayesian Evidence Synthesis Approach to Estimate Disease Prevalence in Hard-To-Reach Populations: Hepatitis C in New York City
Authors:
Sarah Tan,
Susanna Makela,
Daliah Heller,
Kevin Konty,
Sharon Balter,
Tian Zheng,
James H. Stark
Abstract:
Existing methods to estimate the prevalence of chronic hepatitis C (HCV) in New York City (NYC) are limited in scope and fail to assess hard-to-reach subpopulations with highest risk such as injecting drug users (IDUs). To address these limitations, we employ a Bayesian multi-parameter evidence synthesis model to systematically combine multiple sources of data, account for bias in certain data sou…
▽ More
Existing methods to estimate the prevalence of chronic hepatitis C (HCV) in New York City (NYC) are limited in scope and fail to assess hard-to-reach subpopulations with highest risk such as injecting drug users (IDUs). To address these limitations, we employ a Bayesian multi-parameter evidence synthesis model to systematically combine multiple sources of data, account for bias in certain data sources, and provide unbiased HCV prevalence estimates with associated uncertainty. Our approach improves on previous estimates by explicitly accounting for injecting drug use and including data from high-risk subpopulations such as the incarcerated, and is more inclusive, utilizing ten NYC data sources. In addition, we derive two new equations to allow age at first injecting drug use data for former and current IDUs to be incorporated into the Bayesian evidence synthesis, a first for this type of model. Our estimated overall HCV prevalence as of 2012 among NYC adults aged 20-59 years is 2.78% (95% CI 2.61-2.94%), which represents between 124,900 and 140,000 chronic HCV cases. These estimates suggest that HCV prevalence in NYC is higher than previously indicated from household surveys (2.2%) and the surveillance system (2.37%), and that HCV transmission is increasing among young injecting adults in NYC. An ancillary benefit from our results is an estimate of current IDUs aged 20-59 in NYC: 0.58% or 27,600 individuals.
△ Less
Submitted 14 January, 2018;
originally announced January 2018.
